Letters The GMC: expediency before principle BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7485.252 (Published 27 January 2005) Cite this as: BMJ 2005;330:252 Article Related content Metrics Responses Peer review Related articles Editor's Choice A tough nut to crack Published: 27 January 2005; BMJ 330 doi:10.1136/bmj.330.7485.0-h This Week In The BMJ CMF adjuvant chemotherapy for breast cancer achieves good long term results Published: 27 January 2005; BMJ 330 doi:10.1136/bmj.330.7485.0 Analysis And Comment The path to safer patients Published: 26 October 2006; BMJ 333 doi:10.1136/bmj.39008.535162.94 Editorial The GMC: expediency before principle Published: 30 December 2004; BMJ 330 doi:10.1136/bmj.330.7481.1 See more Cancer drugs remain FDA approved despite lack of benefit, study finds BMJ December 06, 2016, 355 i6568; DOI: https://doi.org/10.1136/bmj.i6568 Johnson & Johnson is ordered to pay $1bn over faulty hip implants BMJ December 06, 2016, 355 i6551; DOI: https://doi.org/10.1136/bmj.i6551 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Trial of novel leukaemia drug is stopped for second time after two more deaths BMJ November 25, 2016, 355 i6376; DOI: https://doi.org/10.1136/bmj.i6376 Promise of new Alzheimer’s drug is dashed after lack of evidence BMJ November 24, 2016, 355 i6362; DOI: https://doi.org/10.1136/bmj.i6362 Cited by... The path to safer patientsFulltext PDF
